Ozempic's Unexpected Impact on Prosthesis Fit and Residual Limb Care
Background
Semaglutide, marketed as Ozempic®, is a widely used GLP-1 receptor agonist for managing type 2 diabetes and obesity. Its efficacy in promoting significant weight loss is well-established. However, for individuals with lower limb amputation who rely on prostheses, substantial changes in body weight can have unforeseen consequences on their prosthetic fit and overall quality of life. The specific interaction between semaglutide-induced weight loss and its effects on residual limb volume, prosthesis use, and care has not been previously documented.
Results
The patient experienced significant and rapid weight loss, shedding 18% of his initial body weight, equating to a total loss of 20 kg. This substantial reduction led to a noticeable decrease in residual limb volume, with circumference measurements showing a decrease of 3 cm at the distal end and 5 cm at the proximal end. This change directly impacted the fit of his existing prosthesis. The most critical finding was the direct correlation between the patient's rapid weight loss and the deterioration of prosthesis fit, necessitating three separate socket modifications and two liner changes within just 4 months of starting semaglutide therapy. Initially, the patient reported increased discomfort and developed mild skin irritation in two distinct areas due to the ill-fitting prosthesis, which subsequently resolved after the necessary adjustments. Prosthesis adherence also saw an initial 25% reduction before returning to baseline levels post-modifications.
Why It Matters
This case report highlights a novel and important consideration for healthcare providers prescribing semaglutide to patients with lower limb amputations. The rapid and significant weight loss induced by GLP-1 agonists can profoundly alter residual limb volume, leading to poor prosthesis fit, discomfort, skin complications, and potentially reduced mobility. Understanding these effects is crucial for proactively managing patient care, preventing complications, and ensuring continued functional independence. Clinicians should anticipate the need for frequent prosthetic adjustments and close monitoring in this patient population, and future larger studies are warranted to quantify these effects and develop best practice guidelines.